National Bank of Canada’s Emergent Biosolutions EBS Stock Holding History

National Bank of Canada’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$6	–	2947
2025 Q2	$6	Sell	1 -240	-100%	-$1.37K	﹤0.01%	2954
2025 Q1	$1.17K	Hold	241	–	–	﹤0.01%	2561
2024 Q4	$2.3K	Sell	241 -957	-80%	-$8.78K	﹤0.01%	2569
2024 Q3	$10K	Buy	1,198 +1,141	+2,002%	+$10.4K	﹤0.01%	2083
2024 Q2	$403	Hold	57	–	–	﹤0.01%	2576
2024 Q1	$247	Hold	57	–	–	﹤0.01%	2629
2023 Q4	$147	Hold	57	–	–	﹤0.01%	2647
2023 Q3	$180	Hold	57	–	–	﹤0.01%	2705
2023 Q2	$418	Sell	57 -96	-63%	-$890	﹤0.01%	2629
2023 Q1	$1.58K	Hold	153	–	–	﹤0.01%	2478
2022 Q4	$1.8K	Hold	153	–	–	﹤0.01%	2505
2022 Q3	$3K	Hold	153	–	–	﹤0.01%	2433
2022 Q2	$5K	Hold	153	–	–	﹤0.01%	2420
2022 Q1	$6K	Hold	153	–	–	﹤0.01%	2504
2021 Q4	$7K	Buy	+153	New	+$6.92K	﹤0.01%	2458

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

National Bank of Canada's EBS Position: Q3 2025 in Review

National Bank of Canada sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 1 share — an estimated $6 sold.

National Bank of Canada first reported a position in EBS in Q4 2021 and held it in 15 quarters. The position peaked at $10K in Q3 2024. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

National Bank of Canada reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
National Bank of Canada sold 1 Emergent Biosolutions share in Q3 2025, an estimated $6.
National Bank of Canada first reported a position in Emergent Biosolutions in Q4 2021 and held it in 15 quarters.
National Bank of Canada's Emergent Biosolutions position peaked at $10K in Q3 2024.
169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.